Breast Cancer Trials

Metastatic Breast Cancer: New Treatments & What's on the Horizon Metastatic breast cancer, also known as advanced, secondary or stage four breast cancer, is breast cancer that has spread beyond the breast to other organs in the body. In this podcast, Professor Rik Thompson discusses why and how cancer metastasizes and why it's so difficult to treat. Tune in for a deep dive into this im...

Hormone Replacement Therapy & Breast Cancer: What You Need to Know The symptoms of menopause can significantly affect a woman's quality of life. Hormone replacement therapy or menopausal hormone therapy (HRT or MHT) is the name for a number of hormone therapies that can be used to treat the symptoms of menopause. In this podcast, Associate Professor Nicholas Wilcken discusses some of the r...

Should You Get Genetic Testing for Breast Cancer Risk? Approximately 5-10% of breast cancers are due to a strong family history or a genetic mutation such as BRCA1 or BRCA2. If you have a strong family history of breast cancer, you may be questioning whether you should have genetic testing. In this podcast, Associate Professor Nicholas Wilcken talks about genetic testing, who should have it, who s...

Why Does Breast Cancer Research Take So Long? Inside the Process New research breakthroughs are always in the news, but it can take years before these treatments are used in the clinic. So why does it take so long? Professor Christobel Saunders explains why the process is a long one and the different phases of clinical trials. Tune in for a deep dive into this important topic. Like this episode? ⁠...

Breast Cancer Trials' Key Achievements - How Far We've Come Breast cancer clinical trials research has played an important role in the improvements to treatments and survival rates, particularly over the last 30 years. In this podcast, Professor Christobel Saunders explains some of the key achievements of this research, which have led to advances in the treatment of breast cancer. Tune in...

When a Drug Shows Promise: What Happens Next in Clinical Trials? Associate Professor Nicholas Wilcken was the Study Chair of the HERA clinical trial, which tested the drug Herceptin and delivered a major breakthrough for women with HER2-positive breast cancer. In this podcast, Associate Professor Wilcken discusses what happens when a drug is proven effective in a clinical trial. Tune in for a deep...

How to Participate in a Clinical Trial & What to Expect Finding a clinical trial that is right for yourself, or for a family member or friend, has never been easier. In this podcast, Professor Bruce Mann explains the two main paths to participating in a clinical trial and what's involved once you're on a trial. Tune in for a deep dive into this important topic. Like this episode? ⁠⁠Fol...

Why Every Clinical Trial Builds on the Last: The Power of Research Breast cancer treatments are constantly evolving and improving because of clinical trials research. Each clinical trial builds on the knowledge gained from past research. In this podcast, Breast Cancer Trials' Director of Research Professor Bruce Mann explains how breast cancer surgery is a good example of the benefits that com...

Inside the ELIMINATE Study: A Clinical Trial Participants' Experience Tameeka Jones was only in her 20s and had a three-year-old daughter when she was diagnosed with breast cancer. Tameeka is a participant in the ELIMINATE clinical trial, which is investigating whether combining two breast cancer treatments before surgery is more effective than one alone, in women diagnosed with large oestroge...

The POEMS Clinical Trial: A Patient's Experience & What it Revealed A diagnosis of breast cancer at the age of 32 was a big shock for Natasha Eaton, who initially thought it would mean she wouldn't be able to have children. Natasha was a participant on the POEMS clinical trial, which was a breakthrough study for women with breast cancer and was aimed at preserving a woman's fertili...

Inside the Consumer Advisory Panel: The Importance of Putting Patients First Women and Men have played an important role in the development and conduct of the Breast Cancer Trials research program for many years. Not only was the Consumer Advisory Panel (CAP) the first committee of its type in Australia, but it has also become a model for other research groups to involve consumers. In this podcast...

Personalised Medicine in Breast Cancer: The Future of Treatment We are hearing more and more about 'personalised medicine' in the treatment of disease, but what is it and how can it be used in the treatment of breast cancer? In this podcast, the former Chair of the Breast Cancer Trials Scientific Advisory Committee Professor Prue Francis, explains how personalised medicine is changing the...

The Different Types of Breast Cancer Trials & How They Help There are many different types of clinical trials, such as prevention trials, treatment trials, or trials that are aimed at improving a patient's quality of life. In this podcast, Professor Kelly-Anne Phillips explains the different types of breast cancer clinical trials, the different phases of trials, and also explains the roles...

Neoadjuvant Therapy: What is it and When is it Used? Neoadjuvant therapy refers to treatment before surgery, and it aims to shrink the breast cancer in size to increase the chance of breast-conserving surgery and to monitor the effect of treatment on the tumour. In this podcast, Professor Prue Francis, Former Chair of the Breast Cancer Trials Scientific Advisory Committee, explains the potential b...